Powered by

Crinetics Pharmaceuticals to Participate in Piper Jaffray 30th Annual Healthcare Conference

Nov 20, 2018 - GlobeNewswire

SAN DIEGO, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that Scott Struthers, Ph.D., Founder and Chief Executive Officer, will participate in a fireside chat at the Piper Jaffray 30th Annual Healthcare Conference on Wednesday, November 28, 2018 at 4 p.m. ET (1 p.m....